.

Aptinyx Inc reported $92.14M in Current Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 532.52M 9.7M
Acorda Therapeutics ACOR:US $ 76.52M 3.93M
Biogen BIIB:US $ 9740.9M 1825M
Cara Therapeutics CARA:US $ 176.17M 24.4M
Daiichi Sankyo 4568:JP Y 1367130M 21859M
Eli Lilly And LLY:US $ 17115.2M 150.5M
Halozyme Therapeutics HALO:US $ 541.94M 446.75M
Intra Cellular Therapies ITCI:US $ 789.21M 59.14M
IONIS PHARMACEUT IONS:US $ 2191.15M 61.98M
Marinus Pharmaceuticals MRNS:US $ 101.09M 33.98M
Neurocrine Biosciences NBIX:US $ 1019.3M 1.1M
Novartis NOVN:VX 38.14B 906M
Ultragenyx Pharmaceutical RARE:US $ 678.54M 28.98M
Vertex Pharmaceuticals VRTX:US $ 11503.5M 1142.2M